The Indian Pharmaceutical Alliance has approached regulator for a dialogue to understand the concern raised by it
The broader markets ended negatively with mid-caps and small-caps shedding 0.5 per cent on the BSE.
Benchmark indices finished higher on hopes of economic reforms
Natco Pharma, Wockhardt and Marksans have rallied between 50 and 70 per cent in the year till date.
The FMCG index gained more than 1% on the back of stellar gains in ITC.
The 30-share Sensex ended down 261 points at 27,177 and the 50-share Nifty ended down 91 points at 8,214.
The 30-share Sensex ended higher by 177.46 points at 28,885.21 and the Nifty gained 63.90 points at 8,778.30.
More, many market gurus expect the Sensex to reach 30,000 levels by December and 40,000-45,000 in three to four years.
Five of the 12 BSE sectoral indices ended at 52-week highs; the oil and gas index zoomed by nearly 5%.
Details on prices sought as 10 generic drugs become up to 83 times costlier in 6 months
And when an inspector asked about the contents of unlabelled vials in the laboratory glassware washing area, a plant worker dumped them down a sink and said the contents could not be determined, according to a July 18 letter from the US Food and Drug Administration to Wockhardt, which makes sterile injectable drugs and various forms of insulin.
India Inc did not perform well during December quarter.
In a surprise announcement in April, Sun and Ranbaxy -- at that time owned by Japan's Daiichi -- declared an all-stock deal to create India's largest and world's fifth-largest drugmaker in an over $4 billion deal.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances